Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) - Agnies M. van Eeghen; Elizabeth A. Thiele; Sam Amin; Debopam Samanta; Anna C. Jansen; Joanne Stevens; Lisa Moore-Ramdin; Petrus J. de Vries (PLoS ONE)